// App-Quantinova.ai

1713 : A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia

Researchers

Presenter

  • Yosra Aljawai

Principal Investigators

  • Serena McDiarmid

  • Joseph Cappuccio

  • Federico Campigotto

  • Steven P Treon

  • Edie A. Weller

  • Brenda M. Birmann

  • Irene M. Ghobrial

Medical Centers

  • Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

  • Channing Division of Network Medicine, Department of Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, MA

  • Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Urology

Disease

  • Waldenstrom’s macroglobulinemia

  • Lympho proliferative disease

  • Hematological malignancies

  • Inflammatory bowel disease

  • B-Cell Non-Hodgkin Lymphoma

  • Rheumatoid arthritis

  • Renal insufficiency

  • Hodgkin's Lymphoma

  • Ulcerative colitis

  • Diabetes

  • Venous thrombosis

  • Crohn's disease

  • Prostate cancer

  • Endometrial Cancer

  • Breast cancer

  • Colorectal Cancer

  • Osteoporosis

  • Lung Cancer

  • Osteopenia

  • Inflammatory Arthritis

  • Lymphomas

  • Multiple Myeloma

  • Stroke

  • Anemia

  • Solid malignancies

  • Monoclonal gammopathy

Biomarkers

  • L-plastin

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved